TAZ 抗体 (AA 201-292) (Biotin)
Quick Overview for TAZ 抗体 (AA 201-292) (Biotin) (ABIN1700077)
抗原
See all TAZ 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 201-292
-
预测反应
- Human,Mouse,Rat,Dog,Cow,Sheep
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human Tafazzin
-
亚型
- IgG
-
-
anti-Tafazzin (TAZ) (AA 1-262) antibody
TAZ 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 1B10 unconjugated
anti-Tafazzin (TAZ) (AA 32-60) antibodyTAZ 适用: 人 WB, ELISA, IHC, FACS 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 1-100) antibodyTAZ 适用: 人, 小鼠, 大鼠 WB, ELISA, IF (cc), IF (p), FACS, ICC, IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 46-240) antibodyTAZ 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 95-262) antibodyTAZ 适用: 人 ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 154-292) antibodyTAZ 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (AA 32-60), (N-Term) antibodyTAZ 适用: 人 WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB21836 unconjugated
anti-Tafazzin (TAZ) (AA 1-262) antibodyTAZ 适用: 人 ELISA, IF 宿主: 小鼠 Monoclonal 3C10 unconjugated
anti-Tafazzin (TAZ) (AA 46-239) antibodyTAZ 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Tafazzin (TAZ) (C-Term) antibodyTAZ 适用: 人 ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C for 12 months.
-
有效期
- 12 months
-
-
- TAZ (Tafazzin (TAZ))
-
别名
- Tafazzin
-
背景
-
Synonyms: Barth syndrome, Cardiomyopathy dilated 3A X linked, EFE2, Endocardial fibroelastosis 2, Protein G4.5, Tafazzin, TAZ, TAZ protein, TAZ protein, TAZ_HUMAN.
Background: This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
-
基因ID
- 6901
抗原
-
